{
    "nctId": "NCT00702858",
    "briefTitle": "Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer",
    "officialTitle": "Pilot, Single Center Randomized Controlled, Double-Blind, Cross Over, Intent to Treat Trial of Blue Citrus to Placebo in Those Breast Cancer Patients Receiving Aromatase Inhibitor Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Joint Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Determine if Blue Citrus decreases musculoskeletal symptoms while on AIT as compared to Placebo",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Post Menopausal - evidenced by no menses for the past 6 months or FSH level \\>40\n2. Patient complaints of musculoskeletal symptoms\n3. Currently taking AIT for ER positive postmenopausal breast cancer\n\nExclusion Criteria:\n\n1. Previously taken Blue Citrus\n2. Presence of bone metastasis\n3. Unable to complete VAS Pain Scale\n4. Unable to comply/complete SF 12 Quality of Life survey\n5. Plan to discontinue AIT in less then six months\n6. Unable to complete ADL scale\n7. Have diagnosis of fibromyalgia\n8. Have diagnosis of rheumatoid arthritis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}